Β3-adrenoreceptor As Prognostic Marker in Neuroblastoma and Ewing Sarcoma
Clinical trial NCT06851221 · COMPLETED
Trial details
- NCT number
- NCT06851221
- Sponsor
- Meyer Children's Hospital IRCCS
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-05
- Primary completion
- 2024-03-05
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.